Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „Nucala“
Suchtreffer
Begriffe & Kennungen
Nucala · 4.8 · In the 32-week placebo-controlled study, 1 patient (2%) reported a systemic (other) reaction in the group rece
Eintrag öffnenNucala · 4.8 · In the 32-week placebo-controlled study, 1 patient (2%) reported a systemic (other) reaction in the group rece
Eintrag öffnenNucala · 4.8 · In the 52- to 104-week placebo-controlled study, systemic allergic (type I hypersensitivity) reactions were re
Eintrag öffnenNucala · 4.8 · In the 52- to 104-week placebo-controlled study, systemic allergic (type I hypersensitivity) reactions were re
Eintrag öffnenNucala · 4.8 · In the 52-week placebo-controlled study the percentage of patients who experienced systemic (allergic and non-
Eintrag öffnenNucala · 4.8 · In the 52-week placebo-controlled study the percentage of patients who experienced systemic (allergic and non-
Eintrag öffnenNucala · 4.8 · In the 52-week placebo-controlled study, systemic allergic (type I hypersensitivity) reactions were reported i
Eintrag öffnenNucala · 4.8 · In the 52-week placebo-controlled study, systemic allergic (type I hypersensitivity) reactions were reported i
Eintrag öffnenNucala · 4.8 · In the placebo-controlled studies, local injection site reactions occurred in 2% of patients receiving mepoliz
Eintrag öffnenNucala · 4.8 · In the placebo-controlled studies, local injection site reactions occurred in 2% of patients receiving mepoliz
Eintrag öffnenNucala · 4.8 · In the placebo-controlled study, local injection site reactions (e.g., burning, itching) occurred at a rate of
Eintrag öffnenNucala · 4.8 · In the placebo-controlled study, local injection site reactions (e.g., burning, itching) occurred at a rate of
Eintrag öffnenNucala · 4.8 · In the placebo-controlled study, local injection site reactions (e.g., erythema, pruritus) occurred in 2% of p
Eintrag öffnenNucala · 4.8 · In the placebo-controlled study, local injection site reactions (e.g., erythema, pruritus) occurred in 2% of p
Eintrag öffnenNucala · 4.8 · In the placebo-controlled study, local injection site reactions (e.g., pain, erythema, swelling) occurred at a
Eintrag öffnenNucala · 4.8 · In the placebo-controlled study, local injection site reactions (e.g., pain, erythema, swelling) occurred at a
Eintrag öffnenNucala · 4.8 · In the two 52-week placebo-controlled studies, systemic allergic/hypersensitivity reactions were reported in 4
Eintrag öffnenNucala · 4.8 · In the two 52-week placebo-controlled studies, systemic allergic/hypersensitivity reactions were reported in 4
Eintrag öffnenNucala · 4.8 · In three placebo-controlled studies in patients with COPD, the most commonly reported adverse reactions during
Eintrag öffnenNucala · 4.8 · In three placebo-controlled studies in patients with COPD, the most commonly reported adverse reactions during
Eintrag öffnen